Thomas Edward Schoenherr
CIK 2113721 · CEO, Diagnostics · last filed 2026-05-21
Thomas Edward Schoenherr is a CEO, Diagnostics who has filed 2 SEC Form 4 insider transactions across 1 company since 2026. The most recent filing shows the insider sold $69.6K of TEM on May 21, 2026. Across all open-market trades the lifetime net is −$69.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.40M
1
2
-$69.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TEM | CEO, Diagnostics | 107,029 | $50.47 | $5.40M | -$69.6K | 2 | 2026-05-21 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-21 | TEM | Sell (S) | −1,580 | -$69.6K | EDGAR |
| 2026-05-06 | TEM | Grant (A) | +13,642 | $0 | EDGAR |